Steele J, Billington T, Janus E, Moran J
Department of Chemical Pathology, St. Vincent's Hospital, Fitzroy, Victoria, Australia.
Atherosclerosis. 1989 Sep;79(1):47-50. doi: 10.1016/0021-9150(89)90032-4.
Comparison of lipid, lipoprotein and apolipoprotein levels was made between 3 groups: continuous ambulatory peritoneal dialysis patients (n = 5); haemodialysis patients (n = 15) and normals (n = 31). Continuous ambulatory peritoneal dialysis (CAPD) patients showed significantly elevated total cholesterol, low density lipoprotein (LDL)-cholesterol and apolipoprotein B (apo B) levels compared with haemodialysis and normal groups. Both CAPD and haemodialysis (HD) showed reduced levels of high density lipoprotein (HDL)-cholesterol and apolipoprotein A-I (apo A-I). Measurement of apo A-I and apo B in dialysate during a 6 h CAPD session indicated significant losses of apo A-I to dialysate with negligible losses of apo B. Grossly elevated apo B and reduced apo A-I indicates that CAPD patients are at increased risk of coronary heart disease and that their risk is probably greater than for haemodialysis patients.
对三组人群的脂质、脂蛋白和载脂蛋白水平进行了比较:持续性非卧床腹膜透析患者(n = 5);血液透析患者(n = 15)和正常人(n = 31)。与血液透析组和正常组相比,持续性非卧床腹膜透析(CAPD)患者的总胆固醇、低密度脂蛋白(LDL)胆固醇和载脂蛋白B(apo B)水平显著升高。CAPD和血液透析(HD)患者的高密度脂蛋白(HDL)胆固醇和载脂蛋白A-I(apo A-I)水平均降低。在6小时的CAPD疗程中对透析液中的apo A-I和apo B进行测量,结果表明apo A-I大量流失到透析液中,而apo B的流失可忽略不计。apo B大幅升高和apo A-I降低表明CAPD患者患冠心病的风险增加,且其风险可能大于血液透析患者。